SOCS1, a negative regulator of cytokine signals and TLR responses, in human liver diseases

Gastroenterology Research and Practice

Volumn , Issue , 2010, Pages

  Naka, Tetsuji ^a   Fujimoto, Minoru ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR;

HEPATITIS; IMMUNE RESPONSE; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVIEW;

EID: 77957958958     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2010/470468     Document Type: Review

References (54)

1. Fujimoto M., Naka T., Regulation of cytokine signaling by SOCS family molecules Trends in Immunology 2003 24 12 659 666
2. Yoshimura A., Naka T., Kubo M., SOCS proteins, cytokine signalling and immune regulation Nature Reviews Immunology 2007 7 6 454 465
3. Naka T., Fujimoto M., Tsutsui H., Yoshimura A., Negative regulation of cytokine and TLR signalings by SOCS and others Advances in Immunology 2005 87 61 122 (Pubitemid 41135899)
4. Palmer D. C., Restifo N. P., Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function Trends in Immunology 2009 30 12 592 602
5. Cassel S. L., Rothman P. B., Chapter 3: role of SOCS in allergic and innate immune responses Advances in Immunology 2009 103 49 76
6. Mostecki J., Showalter B. M., Rothman P. B., Early growth response-1 regulates lipopolysaccharide-induced suppressor of cytokine signaling-1 transcription The Journal of Biological Chemistry 2005 280 4 2596 2605
7. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., Kishimoto T., SOCS-1 participates in negative regulation of LPS responses Immunity 2002 17 5 677 687
8. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A., SOCS1/JAB is a negative regulator of LPS-induced macrophage activation Immunity 2002 17 5 583 591
9. Baetz A., Frey M., Heeg K., Dalpke A. H., Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells The Journal of Biological Chemistry 2004 279 52 54708 54715
10. Gingras S., Parganas E., De Pauw A., Ihle J. N., Murray P. J., Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of Toll-like receptor signaling The Journal of Biological Chemistry 2004 279 52 54702 54707
11. Prle C. M., Woodward E. A., Bisley J., Keith-Magee A., Nicholson S. E., Hart P. H., SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages The Journal of Immunology 2008 181 11 8018 8026
12. Fenner J. E., Starr R., Cornish A. L., Zhang J.-G., Metcalf D., Schreiber R. D., Sheehan K., Hilton D. J., Alexander W. S., Hertzog P. J., Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity Nature Immunology 2006 7 1 33 39
13. Mansell A., Smith R., Doyle S. L., Gray P., Fenner J. E., Crack P. J., Nicholson S. E., Hilton D. J., O'Neill L.A.J. L. A. J., Hertzog P. J., Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation Nature Immunology 2006 7 2 148 155
14. Scott M. J., Liu S., Shapiro R. A., Vodovotz Y., Billiar T. R., Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism Hepatology 2009 49 5 1695 1708
15. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.-C., Wulf G., Rottapel R., Yamaoka S., Lu K. P., Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA Molecular Cell 2003 12 6 1413 1426
16. Okugawa S., Ota Y., Kitazawa T., Nakayama K., Yanagimoto S., Tsukada K., Kawada M., Kimura S., Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages American Journal of Physiology 2003 285 2 C399 C408
17. Kimura A., Naka T., Muta T., Takeuchi O., Akira S., Kawase I., Kishimoto T., Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 17089 17094
18. Naka T., Tsutsui H., Fujimoto M., Kawazoe Y., Kohzaki H., Morita Y., Nakagawa R., Narazaki M., Adachi K., Yoshimoto T., Nakanishi K., Kishimoto T., SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN- and IL-4 signaling in vivo Immunity 2001 14 5 535 545
19. Alexander W. S., Starr R., Fenner J. E., Scott C. L., Handman E., Sprigg N. S., Corbin J. E., Cornish A. L., Darwiche R., Owczarek C. M., Kay T. W. H., Nicola N. A., Hertzog P. J., Metcalf D., Hilton D. J., SOCS1 is a critical inhibitor of interferon signaling and prevents the potentially fatal neonatal actions of this cytokine Cell 1999 98 5 597 608
20. Hong F., Jaruga B., Kim W. H., Radaeva S., El-Assal O. N., Tian Z., Nguyen V.-A., Gao B., Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS Journal of Clinical Investigation 2002 110 10 1503 1513
21. Croker B. A., Krebs D. L., Zhang J.-G., Wormald S., Willson T. A., Stanley E. G., Robb L., Greenhalgh C. J., Frster I., Clausen B. E., Nicola N. A., Metcalf D., Hilton D. J., Roberts A. W., Alexander W. S., SOCS 3 negatively regulates IL-6 signaling in vivo Nature Immunology 2003 4 6 540 545
22. Torisu T., Nakaya M., Watanabe S., Hashimoto M., Yoshida H., Chinen T., Yoshida R., Okamoto F., Hanada T., Torisu K., Takaesu G., Kobayashi T., Yasukawa H., Yoshimura A., Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis Hepatology 2008 47 5 1644 1654
23. Ogata H., Kobayashi T., Chinen T., Takaki H., Sanada T., Minoda Y., Koga K., Takaesu G., Maehara Y., Iida M., Yoshimura A., Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis Gastroenterology 2006 131 1 179 193
24. Yoshida T., Ogata H., Kamio M., Joo A., Shiraishi H., Tokunaga Y., Sata M., Nagai H., Yoshimura A., SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis Journal of Experimental Medicine 2004 199 12 1701 1707
25. Seki E., Tsutsui H., Iimuro Y., Naka T., Son G., Akira S., Kishimoto T., Nakanishi K., Fujimoto J., Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration Hepatology 2005 41 3 443 450
26. Campbell J. S., Riehle K. J., Brooling J. T., Bauer R. L., Mitchell C., Fausto N., Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4 The Journal of Immunology 2006 176 4 2522 2528
27. Campbell J. S., Prichard L., Schaper F., Schmitz J., Stephenson-Famy A., Rosenfeld M. E., Argast G. M., Heinrich P. C., Fausto N., Expression of suppressors of cytokine signaling during liver regeneration Journal of Clinical Investigation 2001 107 10 1285 1292
28. Brand S., Dambacher J., Beigel F., Zitzmann K., Heeg M. H. J., Weiss T. S., Prfer T., Olszak T., Steib C. J., Storr M., Gke B., Diepolder H., Bilzer M., Thasler W. E., Auernhammer C. J., IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro American Journal of Physiology 2007 292 4 G1019 G1028
29. Seki E., Kondo Y., Iimuro Y., Naka T., Son G., Kishimoto T., Fujimoto J., Tsutsui H., Nakanishi K., Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings Journal of Hepatology 2008 48 2 237 245
30. Riehle K. J., Campbell J. S., McMahan R. S., Johnson M. M., Beyer R. P., Bammler T. K., Fausto N., Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3 Journal of Experimental Medicine 2008 205 1 91 103
31. Lebrun P., Van Obberghen E., SOCS proteins causing trouble in insulin action Acta Physiologica 2008 192 1 29 36
32. Ueki K., Kondo T., Tseng Y.-H., Kahn C. R., Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse Proceedings of the National Academy of Sciences of the United States of America 2004 101 28 10422 10427
33. Kawazoe Y., Naka T., Fujimoto M., Kohzaki H., Morita Y., Narazaki M., Okumura K., Saitoh H., Nakagawa R., Uchiyama Y., Akira S., Kishimoto T., Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation Journal of Experimental Medicine 2001 193 2 263 269
34. Shi H., Tzameli I., Bjrbk C., Flier J. S., Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling The Journal of Biological Chemistry 2004 279 33 34733 34740
35. Torisu T., Sato N., Yoshiga D., Kobayashi T., Yoshioka T., Mori H., Iida M., Yoshimura A., The dual function of hepatic SOCS3 in insulin resistance in vivo Genes to Cells 2007 12 2 143 154
36. Banks A. S., Li J., McKeag L., Hribal M. L., Kashiwada M., Accili D., Rothman P. B., Deletion of SOCS 7 leads to enhanced insulin action and enlarged islets of Langerhans Journal of Clinical Investigation 2005 115 9 2462 2471
37. Yoshikawa H., Matsubara K., Qian G.-S., Jackson P., Groopman J. D., Manning J. E., Harris C. C., Herman J. G., SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity Nature Genetics 2001 28 1 29 35
38. Nagai H., Kim Y. S., Konishi N., Baba M., Kubota T., Yoshimura A., Emi M., Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas Cancer Letters 2002 186 1 59 65
39. Ko E., Kim S.-J., Joh J.-W., Park C.-K., Park J., Kim D.-H., CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma Cancer Letters 2008 271 2 240 250
40. Gylvin T., Ek J., Nolse R., Albrechtsen A., Andersen G., Bergholdt R., Brorsson C., Bang-Berthelsen C. H., Hansen T., Karlsen A. E., Billestrup N., Borch-Johnsen K., Jrgensen T., Pedersen O., Mandrup-Poulsen T., Nerup J., Pociot F., Functional SOCS1 polymorphisms are associated with variation in obesity in whites Diabetes, Obesity and Metabolism 2009 11 3 196 203
41. Yang X.-P., Schaper F., Teubner A., Lammert F., Heinrich P. C., Matern S., Siewert E., Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo Journal of Hepatology 2005 43 4 704 710
42. Liu X., Zhang Y., Yu Y., Yang X., Cao X., SOCS 3 promotes TLR4 response in macrophages by feedback inhibiting TGF- 1/Smad3 signaling Molecular Immunology 2008 45 5 1405 1413
43. Ogata H., Chinen T., Yoshida T., Kinjyo I., Takaesu G., Shiraishi H., Iida M., Kobayashi T., Yoshimura A., Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF- 1 production Oncogene 2006 25 17 2520 2530
44. Naugler W. E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A. M., Karin M., Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 2007 317 5834 121 124
45. Park E. J., Lee J. H., Yu G.-Y., He G., Ali S. R., Holzer R. G., sterreicher C. H., Takahashi H., Karin M., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 2010 140 2 197 208
46. Nakaya M., Hashimoto M., Nakagawaet R., SOCS 3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis The Journal of Immunology 2009 183 11 7047 7053
47. Fushimi S., Ogino T., Hara J., Takahata T., Wakabayashi H., Watanabe H., Arashima Y., Kubo M., Matsukawa A., Forced expression of suppressor of cytokine signaling 3 in T cells protects the development of concanavalin A-induced hepatitis in mice Clinical Immunology 2009 133 3 437 446
48. Jo D., Liu D., Yao S., Collins R. D., Hawiger J., Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis Nature Medicine 2005 11 8 892 898
49. Koeberlein B., Hausen A. Z., Bektas N., Zentgraf H., Chin R., Toan N. L., Kandolf R., Torresi J., Bock C.- T., Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver Virus Research 2010 148 1-2 51 59
50. Huang Y., Feld J. J., Sapp R. K., Nanda S., Lin J.-H., Blatt L. M., Fried M. W., Murthy K., Liang T. J., Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C Gastroenterology 2007 132 2 733 744
51. Kim K., Kim K. H., Cheong J., Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3 PLoS One 2010 5 3
52. Bode J. G., Ludwig S., Ehrhardt C., Albrecht U., Erhardt A., Schaper F., Heinrich P. C., Hussinger D., IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3 The FASEB Journal 2003 17 3 488 490
53. Kawaguchi T., Yoshida T., Harada M., Hisamoto T., Nagao Y., Ide T., Taniguchi E., Kumemura H., Hanada S., Maeyama M., Baba S., Koga H., Kumashiro R., Ueno T., Ogata H., Yoshimura A., Sata M., Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 American Journal of Pathology 2004 165 5 1499 1508
54. Miyoshi H., Fujie H., Shintani Y., Tsutsumi T., Shinzawa S., Makuuchi M., Kokudo N., Matsuura Y., Suzuki T., Miyamura T., Moriya K., Koike K., Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression Journal of Hepatology 2005 43 5 757 763